Skip to main content
SAGE Open Medical Case Reports logoLink to SAGE Open Medical Case Reports
. 2019 Apr 28;7:2050313X19844379. doi: 10.1177/2050313X19844379

Intra-abdominal lymphatic tuberculosis as a rare case of small intestine volvulus

Filitsa Konstantara 1,2,, Sotiria Stamopoulou 1, Ioannis D Gkegkes 1, Ioannis Kotrogiannis 1, Eleftherios Fotiou 1, Christos Papazacharias 1, Ioannis A Paraskevopoulos 1, Dimitrios Filippou 2, Panagiotis Skandalakis 2
PMCID: PMC6488773  PMID: 31065355

Abstract

Tuberculosis used to be uncommon in the developed countries but seems to be still on rampant in developing countries. However, there seems to be an increasing occurrence in the developed countries too mainly due to low living conditions, increased migration, HIV immune-compromisation and inappropriate use of antitubercular drugs. Lymphatic tuberculosis is the second commonest extrapulmonary location of tuberculosis followed by genitourinary, bone and joint, miliary, meningeal and abdominal. Abdominal tuberculosis represents nearly 11%–16% of all extrapulmonary tuberculosis locations. Furthermore, abdominal tuberculosis co-exists with pulmonary tuberculosis in 10%–30% of patients. Abdominal tuberculosis remains difficult to diagnose due to non-specific symptoms, variable anatomical locations and lack of specific sensitive diagnostic tools. Diagnosis can be rarely suspected, especially in cases of isolated abdominal tuberculosis without clinical or radiological findings. We present a rare case of a patient with pulmonary tuberculosis combined with intra-abdominal lymphatic tuberculosis causing small intestine volvulus.

Keywords: Tuberculosis, abdominal, volvulus, small intestine, ileus

Introduction

According to 2016 World Health Organization’s (WHO) tuberculosis global facts, 10.4 million new cases of tuberculosis (TB) were diagnosed worldwide.1 Seven countries account for 64% of the new cases (India, Indonesia, China, Philippines, Nigeria, Pakistan and South Africa).1 The incidence of TB has increased in developed countries due to immune-compromisation from AIDS, increased immigration from developing countries, where the prevalence of the disease is higher,2 and increased multi-resistant mycobacteria from inappropriate use of antitubercular therapy.3 Several factors determine the probability of transmission including the infectiousness of the source patients, the host’s susceptibility of contacts, the duration of exposure and the environment in which exposure takes place, especially small, poorly ventilated spaces.4 TB involves abdomen as a secondary disease emerging from the reactivation of a dormant focus, acquired somewhere in the past, or as a descending disease when infection spreads to the abdomen via swallowed sputum, hematogenous spread, spread from an infected neighboring organ or ingestion of unpasteurized milk.5,6 Abdominal TB may be enteric (intestine involved itself), peritoneal (as cocoon or ascites), nodal (caseating lymph nodes) and solid visceral TB like liver, spleen, kidney or pancreas or in any combination of these manifestations. The main infecting organism in abdominal TB is Mycobacterium tuberculosis. However, Mycobacterium avium intracellulare is becoming increasingly present in abdominal TB in HIV co-infection.7 In gastrointestinal (GI) tract disease, ingested bacilli pass through Peyer’s patches and are transported to mesenteric lymph nodes via macrophages.7

Case report

A 27-year-old patient from the Republic of Congo presented to our emergency department with severe cramp abdominal pain, vomiting and diarrhea that lasted for 3 days, followed by respite of bowel movements. The patient’s history included only coughing for the past month. Clinical examination revealed abnormal respiratory sounds on the right semi-thoracic area and cough. Mild abdominal distention was noticed on abdominal inspection. No surgical wounds were noticed. On palpitation, diffuse abdominal tenderness was recorded with diffuse guarding and rebound tenderness. Systemic symptoms and signs showed dehydration manifesting as tachycardia and dry mucous membranes. The patient’s temperature was normal and the patient did not mention fever in the last days. Laboratory blood tests were obtained demonstrating the following abnormal test results: C-reactive protein (CRP)—11.2 mg/dL, erythrocyte sedimentation rate (ESR)—46, normal white blood cell count (WBC) but with 90.6% neutrophil count (NEU) and 4.22% lymphocyte count (LYM), hematocrit/hemoglobin (Hct/Hgb)—35.3/11.5, K+—5.2 and lactate dehydrogenase (LDH)—305. A urinary catheter was placed and abdominal and chest X-rays were performed. On chest X-ray, consolidation of the upper zone of the right lung was diagnosed combined with cavities (Figure 1). On abdominal X-ray, in an upright position, typical small bowel obstruction signs were observed with multiple air-fluid levels and distended loops of the small bowel. A nasogastric tube was placed in the emergency department to drain the jejunum content. Per os feeding stopped and intravenous (IV) hydration and empirical antibiotic treatment were set. Contrast-enhanced chest and abdominal computed tomography (CT) was performed and revealed one large cavitation lesion and two smaller cavitation lesions in contact with the former on the upper lobe of the right lung with satellite consolidation lesions compatible with TB (Figure 2). Small bowel obstruction signs were confirmed with distended small bowel loops and diffuse multiple air-fluid levels. In addition, a mass possibly of lymphatic constitution with a proximately 3 cm diameter was demonstrated on the mesentery (Figure 3). Due to high clinical suspicion for specific pulmonary infection, a Mantoux test was performed while the patient’s sputum was collected for smear microscopy. As HIV is a prognostic factor for extrapulmonary TB, a full virological blood test was sent for hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV which came out negative.

Figure 1.

Figure 1.

Patient’s chest X-ray demonstrating consolidation of the upper zone of the right lung combined with cavities.

Figure 2.

Figure 2.

Contrast-enhanced chest CT revealing one large cavitation lesion and two smaller cavitation lesions in contact with the former on the upper lobe of the right lung and satellite consolidation lesions.

Figure 3.

Figure 3.

Contrast-enhanced abdominal CT demonstrating small bowel obstruction signs with distended small bowel loops and diffuse multiple air-fluid levels and a mass possibly of lymphatic constitution with a proximately 3 cm diameter on the mesentery.

The patient was isolated in a single bed chamber and safety measures were taken by the personnel of the surgical ward. A sputum culture was sent to another hospital’s lab due to lack of potentiality in ours. Within 24 h from the patient’s admission, he developed clinical deterioration and rise in the inflammation measurements despite the conservative treatment. The nasogastric tube had drained 1.5 L of jejunum content. The abdominal tenderness intensified. The patient was led to the operating room where diagnostic laparotomy was performed. The small bowel was found dilated from the Treitz ligament until the middle of the jejunum where a small bowel loop was attached to the mesenteric mass, causing a small bowel volvulus. The loop was detached carefully with no need of enterotomy. The small bowel was recovered to its proper rotation. The mildly ischemic small bowel involved in the volvulus regained its normal complexion after 10 min in warm saline. The mass of the mesentery resembled a caseating necrosis of mesenteric lymph nodes (Figure 4). Material for biopsy and microbiological analysis was obtained from the mass (Figure 5). No other lesions were found although the whole peritoneal cavity was inspected thoroughly.

Figure 4.

Figure 4.

The mass of the mesenter resembling a caseating necrosis of mesenteric lymph nodes.

Figure 5.

Figure 5.

The mass of the mesenter resembling a caseating necrosis of mesenteric lymph nodes after biopsy was obtained.

The result from Mantoux test suggested TB infection and antitubercular therapy with isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA) and ethambutol (EMB) commenced immediately. The sputum smear microscopy was also found positive for mycobacteria infection. The patient was transferred to another hospital due to lack of Pneumology ward in our hospital. He was discharged from the other hospital in 2 weeks, with antitubercular therapy for 6 months and normal bowel movement. The culture results of the sputum came positive for M. tuberculosis after a month. Lӧwenstein–Jensen medium was used for the culture and the results were sent to us from the other hospital’s lab. The biopsy of the mass revealed granulomatous inflammation with central necrosis and infiltration with Langerhans giant cells.

Discussion

A total of 17 million people died from TB in 2016 worldwide.1 TB remains the main cause of death in HIV-positive patients. Both incidence and severity of TB are expected to increase with the increasing incidence of HIV infection. The first test for TB, recognized by the WHO, is Xpert MTB/RIF which is a sputum sample examination that simultaneously detects mycobacterium TB complex and resistance to RIF in less than 2 h.1 Sputum smear microscopy and culture-based methods are still of important diagnostic value. Cultures are essential because (1) smears alone will miss up to 50% of active TB cases, (2) mycobacteria other than M. tuberculosis can produce positive smears and (3) cultures are necessary for drug susceptibility testing (DST).4

Abdomen is involved in 10%–30% of patients with pulmonary disease.8 Acute and prompt diagnosis of abdominal TB remains challenging due to the extremely varied clinical presentation.7 It tends to mimic other diseases that affect the GI tract, including Crohn’s disease, tumors and other infectious diseases.2 Abdominal TB presentations include pain (80%–95%), weight loss (40%–90%), fever (40%–70%), alternating diarrhea and constipation (11%–20%), malabsorption and malaise.8 Clinical evaluation and radiologic examination give indirect evidence of the disease. Plain abdominal radiographs may show calcification within lymph nodes, liver, spleen and pancreas. CT of the abdomen can reveal hepatomegaly, splenomegaly, ascites, small bowel obstruction, mesenteric thickening of 15 mm or signs of perforation.9 Invasive techniques such as colonoscopy are used only for colonic TB. The sensitivity is between 30% and 80% and obtaining 8–10 biopsy samples and 3–4 specimens for culture is advised.9 The laparoscopic evaluation of the peritoneal cavity remains the final invasive diagnostic method. The treatment for extrapulmonary TB involves 6 months of quadruple antitubercular chemotherapy3 with the exception of TB meningitis for which 9- to 12-month treatment is recommended.4 The first 2 months of treatment are the intensive phase and the regimen consists of INH, RIF, PZA and EMB, followed by a continuation phase of 4 months of INH and RIF. However, if therapy is initiated after DSTs and the patient’s isolate is susceptible to both INH and RIF, EMB is not necessary and the intensive phase can consist of INH, RIF and PZA only.10 Surgical treatment has its place in the therapy of TB’s complications such as intestinal perforation, small bowel obstruction, enterocutaneous fistula or excessive hemorrhage.7,11

Conclusion

Abdominal TB is generally responsive to antitubercular treatment and early diagnosis can prevent surgical treatment. Abdominal TB should be considered a surgical problem in acute abdomen. With a number of 9.6 million new cases of TB worldwide, abdominal TB should always be kept in mind as a possible differential diagnosis of bowel obstruction, particularly in the high-incidence countries.12

Footnotes

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Ethical approval: Our institution does not require ethical approval for reporting individual cases or case series.

Funding: The author(s) received no financial support for the research, authorship and/or publication of this article.

Informed consent: Written informed consent was obtained from a legally authorized representative for anonymized patient information to be published in this article. Verbal informed consent was obtained from the patient for their anonymized information to be published in this article.

ORCID iD: Filitsa Konstantara Inline graphic https://orcid.org/0000-0002-4568-8238

References

  • 1. World Health Organization. Tuberculosis global facts 2017, http://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf
  • 2. Mamo JP, Brij SO, Enoch DA. Abdominal tuberculosis: a retrospective review of cases presenting to a UK district hospital. QJM 2013; 106(4): 347–354. [DOI] [PubMed] [Google Scholar]
  • 3. Patel S, Al-Nowfal A, Gould STW. A rare cause of faecal peritonitis: jejunal perforation in a patient undergoing treatment for pulmonary tuberculosis. J Surg Case Rep 2012; 2012: rjs014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis 2010; 14(10): 1226–1232. [PubMed] [Google Scholar]
  • 5. Khan R, Abid S, Jafri W, et al. Diagnostic dilemma of abdominal tuberculosis in non-HIV patients: an ongoing challenge for physicians. World J Gastroenterol 2006; 12(39): 6371–6375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Tomizawa Y, Yecies EB, Craig FE, et al. Peritoneal tuberculosis in an immunocompetent, unknown risk patient. Case Rep Gastrointest Med 2013; 2013: 680763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Rasheed S, Zinicola R, Watson D, et al. Intra-abdominal and gastrointestinal tuberculosis. Colorectal Dis 2007; 9(9): 773–783. [DOI] [PubMed] [Google Scholar]
  • 8. Weledji EP, Pokam BT. Abdominal tuberculosis: is there a role for surgery? World J Gastrointest Surg 2017; 9(8): 174–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Uygur-Bayramiçli O, Dabak G, Dabak R. A clinical dilemma: abdominal tuberculosis. World J Gastroenterol 2003; 9(5): 1098–1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clinical Infectious Diseases 2016; 63: e147–e195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Wu Y-F, Ho C-M, Yuan C-T, et al. Intestinal tuberculosis previously mistreated as Crohn’s disease and complicated with perforation: a case report and literature review. Springerplus 2015; 4: 326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Evans R, Mourad MM, Dvorkin L, et al. Hepatic and intra-abdominal tuberculosis: 2016 update. Curr Infect Dis Rep 2016; 18: 45. [DOI] [PubMed] [Google Scholar]

Articles from SAGE Open Medical Case Reports are provided here courtesy of SAGE Publications

RESOURCES